Navigation Links
Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons
Date:9/26/2011

relief, so a new therapy like EXPAREL, which blocks the pain at its source for up to three days and potentially reduces the need for opioids, could be a game changer."

Also at ASPS, new data from a two-year observational study of EXPAREL following breast augmentation were presented during an oral session on Saturday, September 24, 2011. The study, a long-term follow-up of 94 subjects enrolled in prior Phase 2 and Phase 3 studies who underwent breast augmentation at multiple sites in the U.S. and received either bupivacaine or EXPAREL, evaluated patients from 13 to 24 months following surgery; new key finding include:

  • EXPAREL did not have any impact on normal healing in the presence of silicone breast implant material.
  • There was no meaningful difference in impact on breast appearance or implant material in the bupivacaine versus EXPAREL groups.
  • Neither EXPAREL nor bupivacaine were associated with any serious adverse events, deaths or withdrawals from the study.

"EXPAREL represents a much needed advance in perioperative, site-specific pain relief therapies, and this study demonstrates the long-term safety profile of EXPAREL following breast augmentation," said Harold Minkowitz, M.D., the study's lead author and a staff anesthesiologist at Memorial Hermann Memorial City Medical Center in Houston, Texas. "After evaluating patients for up to two years after the procedure, we concluded that EXPAREL did not interfere with the patient's healing process or the integrity of the implant material, and was not associated with any late-stage adverse events."

According to the ASPS, breast augmentation has been the most performed cosmetic surgical procedure since 2006. In 2010, approximately 296,000 breast augmentations were performed, 60 percent of which used silicone implants.(1) In the last decade, the number of breast augmentations performed has increased by 39 percent.(1)

"We are
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
8. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
10. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014  The objective of this market insight ... and research facilities across North America ... study carries out an assessment of the current and ... and law enforcement forensics labs. It also provides a ... PPE segments, and safety regulations specific to labs and ...
(Date:9/23/2014)... PARIS , September 23, 2014 /PRNewswire/ ... tels que l,automobile, la santé, le ferroviaire ... en plus connectées, donneront progressivement accès à ... issues des nombreux capteurs installés au cœur ... estime à plusieurs dizaines de milliards le ...
(Date:9/23/2014)... Sept. 23, 2014 Research and ... "Physician Office Laboratory Markets, 3rd Edition" ... report, Physician Office Laboratory Markets is Kalorama,s complete ... industry. Physician office laboratories are diverse in their ... reimbursable, in-office pregnancy and glucose tests. Some specialty ...
Breaking Medicine Technology:Personal Protective Equipment (PPE) Outlook for the North American and Western European Labs and Research Facilities 2Personal Protective Equipment (PPE) Outlook for the North American and Western European Labs and Research Facilities 3Altran transforme le big data du monde industriel en nouveau business 2Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3
(Date:9/23/2014)... (PRWEB) September 23, 2014 Oaksterdam University ... Today . In its first post, the University addresses ... and changing cannabis industry. , The cannabis industry is ... alone is expecting an 18-month boost of more than ... adult use pot sales. And, the new legal recreational ...
(Date:9/23/2014)... NIH TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF ... WHAT: , The National Institutes of Health is ... available scientific evidence on the long-term effectiveness and potential ... be among the nation,s top experts in the field ... as well as key NIH scientists who focus on ...
(Date:9/23/2014)... 2014 As a consumer in today’s ... purchase. It’s difficult to trust testimonials that are supplied ... to manipulate their customers into saying anything. , Consumer ... tend to lack in depth coverage on a particular ... founded to fix this issue and focus on exposing ...
(Date:9/23/2014)... Sept. 23, 2014 (HealthDay News) -- Both drinking and ... factors for alcohol abuse by high school students, a ... survey of high school students who drink, could help ... who already drink, to stop them from becoming binge ... between age of first alcohol use and progression to ...
(Date:9/23/2014)... 23, 2014 What: Rutgers Presbyterian ... West Side that embodies the inclusion and diversity ... Scripture and the Ecological Crisis, a public lecture ... Professor Emerita of Old Testament at Louisville Presbyterian ... wisdom that lends insight into current ecological problems, ...
Breaking Medicine News(10 mins):Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2
... Annual and Special Meeting web cast live, LAVAL, ... Special,meeting of Neurochem Inc. (NASDAQ: NRMX ; TSX: ... new name, BELLUS Health Inc., which,it expects to start ... stock,ticker symbols (NASDAQ: BLUS ; TSX: BLU). Neurochem ...
... 15 Heritage Pharma Ltd.,(U.K.) and its wholly ... the Company has consummated the,private placement of Series ... capital investors McClendon Venture Company, LLC and,TLW Venture ... prior to fees,and expenses. The proceeds will be ...
... a high frequency of sleep-related breathing disorders (SRBD) in ... an overnight sleep test, especially in patients with underlying ... April 15 issue of the Journal of Clinical Sleep ... MD, of Johns Hopkins University and Bayview Medical Center ...
... Allergies and asthma affect,six times more Americans than ... America. As the fifth leading chronic disease, allergies,along ... Americans., (Photo: http://www.newscom.com/cgi-bin/prnh/20080415/NYTUFNS1 ), ... to prevent or treat,allergies and asthma," said Peggy ...
... therapy shows promise against pancreatic tumors, scientists say , , ... drug duo might help prevent colorectal cancer, and the ... of liver cancer. , So conclude two studies presented ... meeting in San Diego. , In the first report, ...
... Position Company to Meet Strategic ... Growth Objectives, ... global full-service clinical research organization, today,announced the promotion of Simon S. ... as President and Chief Operating,Officer, will continue as Chief Operating Officer. ...
Cached Medicine News:Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 2Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 3Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 4Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 5Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 6Health News:Heritage Announces $10 Million Financing 2Health News:JCSM: A high frequency of sleep-related breathing disorders in hospitalized patients 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 5Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 6Health News:New Treatments Help Fight Liver, Colon Cancer 2Health News:New Treatments Help Fight Liver, Colon Cancer 3Health News:New Treatments Help Fight Liver, Colon Cancer 4Health News:Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer 2Health News:Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer 3
Indicated for procedures of the wrist, ankle, elbow, and other small joints, the,UltrAblator is effective for ablation of soft tissue and coagulation of bleeders,encountered during surgery....
... This implant is designed to replace the ... on the distal pole which fits under a ... bone, and a suture hole on the proximal ... anatomical position during the early postoperative period until ...
... has the same anatomical configuration as the ... to provide for stability. The implant has ... use in suture fixation through the scaphoid ... while a capsuloligamentous system forms around the ...
... for four corner fusion of the capitate, ... hand. The plate is intended for use ... of function due to SLAC and SNAC ... rheumatoid arthritis. When combined with the specially ...
Medicine Products: